[{"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-001", "question": "A 68-year-old man with a history of severe aortic stenosis (mean gradient 48 mmHg, AVA 0.7 cm²) presents with decompensated heart failure. He is hypotensive (85/50 mmHg) and hypoxic despite high-flow oxygen. Transthoracic echocardiography shows a hyperdynamic left ventricle with near-cavity obliteration, severe mitral regurgitation (new, eccentric posteriorly directed jet), and systolic anterior motion of the mitral valve with LVOT obstruction (peak gradient 120 mmHg). Which of the following is the single most appropriate immediate pharmacologic intervention?", "options": ["Intravenous phenylephrine infusion", "Intravenous esmolol infusion", "Intravenous nitroglycerin infusion", "Intravenous furosemide bolus", "Intravenous milrinone infusion"], "answer": "A", "answer_index": 0, "explanation": "This patient has severe aortic stenosis with a dynamic LVOT obstruction (systolic anterior motion) precipitated by hypovolemia and hypercontractility, leading to hypotension and secondary mitral regurgitation. Phenylephrine, an alpha-agonist, increases afterload and blood pressure, which reduces the LVOT gradient and improves forward flow. Esmolol (negative inotrope) could worsen heart failure in the setting of severe AS. Nitroglycerin and furosemide reduce preload, exacerbating the obstruction. Milrinone is a positive inotrope and vasodilator, which would dramatically worsen the LVOT gradient and hypotension.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "This patient presents with cardiogenic shock characterized by dynamic left ventricular outflow tract (LVOT) obstruction due to systolic anterior motion (SAM) of the mitral valve. This is a known complication in patients with left ventricular hypertrophy (caused here by severe aortic stenosis) who become hypovolemic or possess a hyperdynamic ventricle (often due to endogenous catecholamine surge in response to stress).\n\nThe echocardiographic findings—hyperdynamic LV with cavity obliteration, severe MR from SAM, and a gradient significantly higher than the baseline fixed AS gradient—confirm that the primary hemodynamic insult is the dynamic obstruction, not the fixed valve stenosis. The pathophysiology mimics Hypertrophic Obstructive Cardiomyopathy (HOCM).\n\nManagement focuses on reducing the LVOT gradient by:\n1.  Increasing Preload: To expand the LV cavity size (moving the septum away from the mitral valve).\n2.  Increasing Afterload: To increase systolic pressure in the LVOT, distending the outflow tract and reducing the pressure drop that sucks the valve leaflet in (Venturi effect).\n3.  Decreasing Contractility: To reduce the velocity of flow and the force of ejection.\n4.  Decreasing Heart Rate: To increase filling time.\n\nLet's review the options:\n*   A. Intravenous phenylephrine infusion: Phenylephrine is a pure alpha-agonist. It increases systemic vascular resistance (afterload) without increasing contractility. Increasing afterload is beneficial in dynamic LVOT obstruction as it helps reduce the obstruction gradient. Furthermore, it treats the hypotension (85/50 mmHg). It is the vasopressor of choice in this scenario.\n*   B. Intravenous esmolol infusion: Beta-blockers reduce contractility and heart rate, which is mechanistically beneficial for SAM. However, in a patient with active hypotension (SBP 85 mmHg) and shock, initiating a negative inotrope/chronotrope is dangerous and could precipitate immediate cardiovascular collapse.\n*   C. Intravenous nitroglycerin infusion: This is a vasodilator. It reduces preload and afterload, leading to a smaller LV cavity and lower resistance to ejection. This will critically worsen SAM, increase the obstruction, and worsen hypotension. It is contraindicated.\n*   D. Intravenous furosemide bolus: Diuretics reduce preload. A smaller LV cavity brings the mitral leaflet closer to the septum, worsening the obstruction and the specific \"SAM-related\" MR. Despite the hypoxia, volume expansion or maintenance is often required, and diuresis can be fatal.\n*   E. Intravenous milrinone infusion: Milrinone is an inotope and vasodilator. Increased contractility and decreased afterload will severely exacerbate dynamic obstruction. It is contraindicated.\n\nThe immediate goal is to stabilize blood pressure and reduce the gradient. Phenylephrine achieves this by increasing afterload and raising blood pressure, which reflexively may lower heart rate, without increasing contractility.\n\nThe answer is (A)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-002", "question": "A 3-day-old full-term neonate, born via uncomplicated vaginal delivery, is noted to have progressive tachypnea, grunting, and hypoxemia requiring 60% FiO2. Chest X-ray shows diffuse granular opacities with air bronchograms. Surfactant administration provides minimal improvement. Echocardiogram shows normal cardiac anatomy, but there is severe pulmonary hypertension with suprasystemic right ventricular pressures and right-to-left shunting across a patent foramen ovale. Which of the following underlying conditions is the most likely cause of this refractory pulmonary hypertension of the newborn?", "options": ["Congenital alveolar capillary dysplasia", "Meconium aspiration syndrome", "Transient tachypnea of the newborn", "Group B streptococcal pneumonia", "Idiopathic respiratory distress syndrome"], "answer": "A", "answer_index": 0, "explanation": "Congenital alveolar capillary dysplasia (ACD) with misalignment of pulmonary veins is a rare, lethal lung developmental disorder that presents identically to severe persistent pulmonary hypertension of the newborn (PPHN) but is completely refractory to all standard therapies, including surfactant, inhaled nitric oxide, and ECMO. The history of a full-term infant with rapid progression and lack of response to surfactant is classic. Meconium aspiration and sepsis can cause severe PPHN but typically show some response to aggressive management. Transient tachypnea and idiopathic RDS are not associated with such severe, immediate refractory pulmonary hypertension.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "This clinical vignette describes a full-term neonate with severe respiratory distress, diffuse granular opacities on chest X-ray (resembling RDS), and severe, refractory pulmonary hypertension (suprasystemic RV pressures) wth a normal echocardiogram (ruling out structural heart defects).\n\nKey features in the reasoning:\n1.  Patient Demographics: The infant is full-term. \"Idiopathic respiratory distress syndrome\" (Option E), also known as Hyaline Membrane Disease, is primarily a condition of prematurity due to surfactant deficiency. While full-term infants can develop RDS (e.g., infants of diabetic mothers), it is uncommon, and the lack of response to surfactant argues against simple surfactant deficiency.\n2.  Radiographic Findings: The \"diffuse granular opacities with air bronchograms\" is the classic appearance of RDS or Group B Streptococcal (GBS) pneumonia. However, it is also a reported appearance in Alveolar Capillary Dysplasia (ACD), which can present with diffuse haziness or ground-glass opacities mimicking RDS or pneumonia.\n3.  Refractory Clinical Course: The defining feature of this case is the refractory pulmonary hypertension (PPHN) and hypoxemia that shows \"minimal improvement\" with surfactant administration.\n    *   GBS Pneumonia (Option D) can cause PPHN and radiographic changes similar to RDS, but it typically responds to antibiotics, respiratory support, and inhaled nitric oxide. The label \"refractory\" strongly points toward a lethal structural anomaly rather than an infection.\n    *   Meconium Aspiration Syndrome (Option B) usually presents with patchy infiltrates and hyperinflation, not diffuse granular opacities, and there is no history of meconium-stained fluid.\n    *   Transient Tachypnea of the Newborn (Option C) presents with perihilar streaking and fluid in the fissures, not granular opacities, and is generally self-limiting.\n4.  The Diagnosis: Congenital Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins (ACD/MPV) (Option A) is a rare, fatal developmental lung disorder. It typically presents in full-term infants as severe, persistent pulmonary hypertension (PPHN) and hypoxemia that is unresponsive (refractory) to standard therapies like surfactant, high-frequency ventilation, and inhaled nitric oxide (or shows only a very transient \"honeymoon\" response). The echocardiogram is crucial to rule out congenital heart disease, as done here. The combination of term birth, RDS-like X-ray, and lethal/refractory PPHN is the classic board presentation for ACD.\n\nThe answer is (A)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-003", "question": "A 42-year-old woman is brought to the ED after a high-speed motor vehicle collision. Primary survey reveals a Glasgow Coma Scale of 14, heart rate 130 bpm, BP 88/50 mmHg, and SpO2 94% on room air. Focused Assessment with Sonography for Trauma (FAST) is positive for fluid in the hepatorenal recess. After initiating a massive transfusion protocol, her blood pressure transiently improves with crystalloid, then drops again. Bedside ultrasound now shows a new, large pericardial effusion with diastolic right ventricular collapse. Which of the following is the most appropriate immediate procedural intervention?", "options": ["Emergency department thoracotomy", "Pericardiocentesis via subxiphoid approach", "Left anterolateral tube thoracostomy", "Right tube thoracostomy", "Laparotomy with aortic cross-clamping"], "answer": "B", "answer_index": 1, "explanation": "The patient has developed cardiac tamponade (evidenced by diastolic RV collapse on ultrasound) in the context of trauma and a positive FAST exam, suggesting concurrent intra-abdominal hemorrhage. In blunt trauma, the cause is likely myocardial rupture or coronary vessel injury. Pericardiocentesis is the immediate life-saving procedure to relieve tamponade while simultaneously preparing for definitive operative management. ED thoracotomy is indicated for penetrating trauma with recent loss of signs of life. Tube thoracostomy addresses hemothorax, not pericardial tamponade. Laparotomy addresses the abdominal hemorrhage but would not relieve the cardiac tamponade, and the patient would likely arrest on induction of anesthesia.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "This patient presents with signs of obstructive shock due to cardiac tamponade (hypotension, tachycardia, distended neck veins [implied], and ultrasound findings of pericardial effusion with diastolic RV collapse) in the setting of blunt trauma. She also has evidence of intra-abdominal hemorrhage (positive FAST in hepatorenal recess).\n\nThe management priorities follow the ABCs. While she has hemorrhagic shock, the cardiac tamponade provides a mechanical obstruction to cardiac filling that must be relieved immediately to restore cardiac output. Volume resuscitation has failed to sustain blood pressure, and induction of anesthesia for a laparotomy (Option E) in a patient with untreated tamponade can precipitate cardiovascular collapse and cardiac arrest due to the loss of sympathetic drive and the effects of positive pressure ventilation (which further decreases venous return).\n\nLet's analyze the options:\n*   A. Emergency department thoracotomy (EDT): This is generally indicated for patients with penetrating trauma who arrest or are peri-arrest (lose signs of life) in the ED. In blunt trauma, survival rates for EDT are extremely poor (<1-2%), and it is generally contraindicated in patients who are not in cardiac arrest and have a GCS of 14 (indicating relatively preserved cerebral perfusion).\n*   B. Pericardiocentesis via subxiphoid approach: In a hemodynamically unstable trauma patient with confirmed cardiac tamponade, the definitive treatment is surgical exploration (sternotomy) to control the bleeding source. However, as an immediate procedural intervention in the ED to temporize the patient and improve hemodynamics (bridge to the OR), pericardiocentesis is the most appropriate choice among the listed options. It relieves the obstructive shock, allowing the heart to fill, and stabilizes the patient for transport to the operating room for definitive repair of the chest and abdomen.\n*   C & D. Tube thoracostomy: These are used for pneumothorax or hemothorax. There is no evidence of these conditions in the scenario (e.g., absent breath sounds, pleural fluid on ultrasound).\n*   E. Laparotomy with aortic cross-clamping: This addresses the abdominal bleeding but ignores the immediate life-threat of tamponade. As noted, performing this without relieving the tamponade is dangerous.\n\nTherefore, immediate decompression of the pericardium is required.\n\nThe answer is (B)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-004", "question": "A 28-year-old woman presents with a 6-month history of symmetric inflammatory polyarthritis affecting her wrists, MCPs, and knees, morning stiffness >1 hour, and a new facial rash. Labs show ANA 1:1280 (speckled), anti-dsDNA negative, anti-Smith positive, anti-RNP positive, complement levels normal, and urinalysis with 2+ protein but no cellular casts. She is started on hydroxychloroquine. Two weeks later, she develops acute dyspnea, pleuritic chest pain, and hypoxia. CT pulmonary angiography shows no pulmonary embolism but reveals extensive bilateral ground-glass opacities and pleural effusions. Which of the following is the most likely diagnosis?", "options": ["Lupus pneumonitis", "Drug reaction to hydroxychloroquine", "Acute pulmonary hemorrhage from vasculitis", "Pulmonary hypertension due to SLE", "Opportunistic infection due to immunosuppression"], "answer": "A", "answer_index": 0, "explanation": "The patient has SLE (meeting criteria with arthritis, malar rash, anti-Smith positivity). The acute respiratory presentation with ground-glass opacities and pleural effusions in this context is most consistent with acute lupus pneumonitis, a rare but severe manifestation of SLE. Timing makes drug reaction unlikely, as hydroxychloroquine toxicity is typically chronic and not acute pulmonary. Pulmonary hemorrhage would show falling hematocrit and more alveolar filling. Pulmonary hypertension is a chronic process. Opportunistic infection is improbable given the very short course of a minimally immunosuppressive agent (hydroxychloroquine).", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "In this clinical scenario, the patient is a young woman recently diagnosed with Systemic Lupus Erythematosus (SLE). Her diagnosis is supported by the malar rash, symmetric polyarthritis, proteinuria, high titer ANA, and specific antibodies (Anti-Smith).\n\nHere is an analysis of the options:\n\n*   A. Lupus pneumonitis: This is a rare (>5% of SLE patients) but severe, acute manifestation of SLE. It typically presents with the abrupt onset of dyspnea, fever, cough, pleuritic chest pain, and hypoxia. Imaging (CT) characteristically reveals bilateral alveolar infiltrates (ground-glass opacities), consolidation, and pleural effusions. The patient has active disease in other domains (joints, skin, kidney), and this pulmonary presentation occurring shortly after diagnosis (implying the disease is active and perhaps not yet fully controlled by the slow-acting hydroxychloroquine) fits the profile of acute lupus pneumonitis well.\n*   B. Drug reaction to hydroxychloroquine: Acute pulmonary toxicity from hydroxychloroquine is exceedingly rare. While it can cause neuromyopathy or restrictive lung disease after long-term use, an acute pneumonitis with ground-glass opacities just two weeks after initiation is not a characteristic side effect.\n*   C. Acute pulmonary hemorrhage from vasculitis: Diffuse alveolar hemorrhage (DAH) is a life-threatening complication of SLE that can present similarly with dyspnea and bilateral infiltrates. However, it is classically associated with hemoptysis (though can be occult) and a significant drop in hemoglobin. While DAH is a differential consideration, the term \"lupus pneumonitis\" specifically describes the acute inflammatory process (capillaritis/alveolar damage) resulting in the described imaging findings in the absence of frank hemorrhage confirmation. Furthermore, DAH is often associated with high anti-dsDNA and low complement, which this patient does not have.\n*   D. Pulmonary hypertension due to SLE: This typically presents insidiously with progressive dyspnea and fatigue. CT imaging usually demonstrates clear lung parenchyma (or enlarged pulmonary arteries), not extensive ground-glass opacities and effusions.\n*   E. Opportunistic infection due to immunosuppression: While infection is a major concern in SLE, this patient has only been on hydroxychloroquine for two weeks. Hydroxychloroquine is an immunomodulator, not a potent immunosuppressant, and does not significantly increase the risk of opportunistic infections (like *Pneumocystis jirovecii*) on its own in such a short timeframe compared to high-dose steroids or cytotoxic agents.\n\nTherefore, the clinical picture of acute respiratory distress with ground-glass opacities and effusions in a patient with active SLE is most consistent with acute lupus pneumonitis.\n\nThe answer is (A)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-005", "question": "A 55-year-old man with a history of MEN1 syndrome (previous parathyroidectomy, pancreatic neuroendocrine tumor resection) presents with profound hypoglycemia (glucose 38 mg/dL) and inappropriately elevated serum insulin and C-peptide during a supervised fast. Localizing studies, including endoscopic ultrasound and Ga-68 DOTATATE PET/CT, show no identifiable pancreatic lesion. Which of the following is the most appropriate next step in management?", "options": ["Empiric distal pancreatectomy", "Initiation of diazoxide therapy", "Selective arterial calcium stimulation with hepatic venous sampling", "Empiric total pancreatectomy", "Long-acting somatostatin analog therapy (e.g., lanreotide)"], "answer": "C", "answer_index": 2, "explanation": "In a patient with MEN1 and biochemically proven endogenous hyperinsulinemic hypoglycemia (insulinoma) with negative conventional and advanced imaging, the next step is selective arterial calcium stimulation (SACS) with hepatic venous sampling. This invasive angiographic procedure can regionalize the source of insulin secretion to a specific pancreatic arterial territory (gastroduodenal, superior mesenteric, or splenic arteries), guiding targeted surgical exploration. Empiric distal or total pancreatectomy carries high morbidity and may miss the lesion. Diazoxide and somatostatin analogs are temporizing medical therapies but do not address the need for definitive localization and resection in a surgical candidate.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "This patient presents with biochemical evidence of an insulinoma (Whipple's triad, elevated insulin and C-peptide levels during hypoglycemia) in the context of MEN1 syndrome. MEN1 patients are predisposed to multifocal pancreatic neuroendocrine tumors (pNETs), although often only one is responsible for the insulin hypersecretion. The patient has already undergone prior resection, complicating the anatomy and increasing the likelihood of multifocality or recurrence.\n\nStandard high-resolution imaging (EUS, PET/CT) has failed to localize the lesion. In the setting of an occult insulinoma where non-invasive and endoscopic imaging are negative, the most appropriate next step is selective arterial calcium stimulation with hepatic venous sampling (SACST).\n\nDuring this procedure, calcium (a secretagogue for insulin from insulinoma cells but not normal beta cells) is injected into the arteries supplying different regions of the pancreas (gastroduodenal, superior mesenteric, and splenic arteries). Hepatic venous blood is sampled to detect a surge in insulin levels. This allows the hyperfunctioning tissue to be regionalized to the head (GDA/SMA supply) or body/tail (splenic/SMA supply) of the pancreas. This information guides the surgeon to perform a targeted resection (e.g., distal pancreatectomy vs. Whipple or enucleation) rather than a blind empiric resection or a morbid total pancreatectomy (Choice D).\n\nEmpiric distal pancreatectomy (Choice A) is risky because the tumor might be in the head of the pancreas. Medical management with diazoxide (Choice B) or somatostatin analogs (Choice E) treats symptoms but is not curative and is generally reserved for unclimbable candidates or unresectable disease; localization for curative surgery is the priority.\n\nThe answer is (C)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-006", "question": "A 7-year-old boy is evaluated for short stature. He has a history of congenital hypothyroidism diagnosed on newborn screening, treated with levothyroxine. Growth chart shows length and weight at the 5th percentile at birth, falling to below the 1st percentile by age 3. Current bone age is delayed by 3 years. Physical exam reveals a prominent forehead, depressed nasal bridge, and small hands with brachydactyly. Labs show normal TSH and free T4 on replacement. Which of the following genetic mutations is most likely responsible for this clinical picture?", "options": ["SHOX gene mutation", "GH1 gene mutation (isolated GH deficiency)", "GNAS1 gene mutation (Albright hereditary osteodystrophy)", "PROP1 gene mutation (combined pituitary hormone deficiency)", "FGFR3 gene mutation (achondroplasia)"], "answer": "D", "answer_index": 3, "explanation": "The combination of congenital hypothyroidism, severe postnatal growth failure with delayed bone age, and mild facial dysmorphism is classic for combined pituitary hormone deficiency (CPHD) due to a PROP1 mutation. PROP1 is a pituitary transcription factor critical for the development of somatotrophs, lactotrophs, thyrotrophs, and gonadotrophs. Deficiency presents with growth hormone, TSH, and later gonadotropin deficiencies. The congenital hypothyroidism was central (pituitary), not primary thyroidal. SHOX mutations cause Leri-Weill dyschondrosteosis. GNAS1 mutations cause pseudohypoparathyroidism with specific skeletal findings (brachydactyly type E). Isolated GH deficiency or achondroplasia would not explain the central hypothyroidism.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "This clinical scenario describes a patient with Albright hereditary osteodystrophy (AHO), which is caused by an inactivating mutation in the GNAS1 gene (specifically affecting the Gs-alpha subunit).\n\nHere is the breakdown of the clinical features matching this diagnosis:\n1.  Congenital Hypothyroidism: GNAS1 mutations lead to widespread resistance to hormones that utilize Gs-protein coupled receptors. Resistance to TSH at the thyroid receptor mimics primary hypothyroidism (elevated TSH, low T4), which is typically detected on standard newborn screening.\n2.  Short Stature and Growth Failure: The patient has resistance to Growth Hormone-Releasing Hormone (GHRH), leading to a state of Growth Hormone (GH) deficiency. This explains the growth chart dropping to below the 1st percentile.\n3.  Physical Features:\n    *   Brachydactyly: This is a hallmark skeletal feature of AHO, typically manifesting as shortening of the 4th and 5th metacarpals.\n    *   Prominent forehead and depressed nasal bridge: These are classic features of the GH deficiency phenotype (midfacial hypoplasia) resulting from the GHRH resistance associated with the GNAS1 mutation.\n    *   Delayed Bone Age: Consistent with the GH deficiency/hypothyroidism axis disruption.\n\nWhy other options are incorrect:\n*   A. SHOX gene mutation: Causes Léri-Weill dyschondrosteosis (mesomelic short stature, Madelung deformity) or Turner syndrome stigmata. It does not cause congenital hypothyroidism.\n*   B. GH1 gene mutation: Causes isolated GH deficiency but does not explain the history of congenital hypothyroidism or the specific skeletal dysplasia (brachydactyly).\n*   D. PROP1 gene mutation: Causes Combined Pituitary Hormone Deficiency (deficiencies in GH, TSH, LH, FSH). While this causes short stature and hypothyroidism, the hypothyroidism is *central* (low/normal TSH), which is often missed on TSH-based newborn screening (unlike the primary hypothyroidism of GNAS1). Furthermore, PROP1 deficiency causes proportional small hands (acromicria), whereas \"brachydactyly\" refers to specific bone shortening characteristic of AHO.\n*   E. FGFR3 gene mutation: Causes Achondroplasia. While this presents with short stature, prominent forehead, and depressed nasal bridge, it is not associated with congenital hypothyroidism.\n\nThe answer is (C)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-007", "question": "A 70-year-old man with severe, calcific aortic stenosis (AVA 0.6 cm², mean gradient 55 mmHg) and chronic kidney disease (eGFR 28 mL/min/1.73m²) presents with recurrent hospitalizations for heart failure with preserved ejection fraction (LVEF 65%). He is deemed high-risk for surgical AVR. He undergoes transcatheter aortic valve implantation (TAVI) with a balloon-expandable valve. Immediately post-deployment, transesophageal echocardiography shows a well-seated valve with mild paravalvular leak, mean gradient 8 mmHg, and new severe mitral regurgitation with a wide vena contracta and eccentric anteriorly directed jet. The left ventricular systolic function appears hyperdynamic. What is the most likely mechanism of the acute severe mitral regurgitation?", "options": ["Iatrogenic injury to the mitral valve apparatus from the delivery system", "Dynamic left ventricular outflow tract obstruction causing systolic anterior motion of the mitral valve", "Unmasking of pre-existing severe ischemic mitral regurgitation due to afterload reduction", "Valve prosthesis impingement on the anterior mitral leaflet", "Acute papillary muscle dysfunction due to coronary occlusion"], "answer": "B", "answer_index": 1, "explanation": "In a patient with severe AS and a small, hypertrophied, hyperdynamic left ventricle, relief of the afterload obstruction via TAVI can precipitate dynamic LVOT obstruction. This leads to systolic anterior motion (SAM) of the mitral valve, causing acute, severe mitral regurgitation with an eccentric anterior jet. This is a recognized complication of TAVI, particularly in patients with certain anatomical predictors (septal hypertrophy, small LV cavity). Direct injury from the delivery system is rare. Pre-existing severe MR would have been evident pre-procedure. Prosthetic impingement typically causes central MR. Coronary occlusion is possible but would more likely cause regional wall motion abnormalities and ischemic MR.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "D", "model_outputs": "This question describes a patient who has undergone TAVI and immediately presents with complications. Let's break down the findings to determine the mechanism of the new severe mitral regurgitation (MR).\n\n1.  Patient Profile: 70-year-old with severe AS, preserved EF (65%), and CKD. This high-flow state is prone to hyperdynamic function once the afterload (AS) is relieved.\n2.  Procedure: TAVI with a balloon-expandable valve.\n3.  Post-Deployment Echo:\n    *   \"Well-seated valve\": Implies the aortic prosthesis is stable.\n    *   \"Mild paravalvular leak, mean gradient 8 mmHg\": Successful relief of AS.\n    *   \"New severe mitral regurgitation\": The primary complication.\n    *   \"Eccentric anteriorly directed jet\": This is the critical discriminator.\n    *   \"LV systolic function... hyperdynamic\": Expected after afterload relief and with volume overload from acute MR.\n\nAnalysis of Options:\n\n*   A. Iatrogenic injury to the mitral valve apparatus: The delivery system (guidewire) can injure the mitral valve. However, the wire typically rests along the anterior wall or septum. Injury to the Anterior Mitral Leaflet (AML) would cause a flail leaflet. A flail AML directs the regurgitant jet posteriorly (away from the defect). Injury to the Posterior Mitral Leaflet (PML) would cause an anterior jet, but the PML is anatomically far from the typical wire trajectory, making this unlikely.\n*   B. Dynamic LVOT obstruction (SAM): Post-AVR/TAVI, the relief of afterload in a hyperdynamic, often hypertrophied ventricle can induce Systolic Anterior Motion (SAM) of the mitral valve. This is a common cause of acute MR in this setting. However, in SAM, the AML is pulled into the LVOT, creating a gap posteriorly. Consequently, the MR jet in SAM is classically directed posteriorly and laterally. The presence of an *anteriorly* directed jet makes SAM incorrect.\n*   C. Unmasking of pre-existing ischemic MR: Relief of AS usually reduces LV pressure, which tends to decrease functional (ischemic) MR. Furthermore, functional MR jets are typically central or posteriorly directed (due to P2/P3 tethering).\n*   D. Valve prosthesis impingement on the anterior mitral leaflet: If a TAVI valve (particularly a balloon-expandable one) is deployed too low (ventricularly), the valve frame can mechanically impinge upon the base of the AML. This mechanical interference restricts the motion of the AML, preventing it from closing properly (leaflet restriction). When the AML is restricted and the PML moves normally, the coaptation defect results in a jet directed towards the restricted leaflet (the AML) and along the anterior wall of the left atrium. Thus, AML impingement produces an eccentric anteriorly directed jet. This matches the description perfectly.\n*   E. Acute papillary muscle dysfunction: This typically results from coronary occlusion (e.g., RCA occlusion affects the posteromedial papillary muscle). Ischemic dysfunction usually causes leaflet tethering (posterior jet) or, if ruptured, a flail leaflet. While rupture of the posteromedial papillary muscle causes a flail PML (anterior jet), it is a catastrophic event usually accompanied by severe regional wall motion abnormalities or hemodynamic collapse (shock), rather than a globally \"hyperdynamic\" ventricle. Impingement is a more direct mechanical complication of the valve deployment described.\n\nConclusion: The key finding is the anteriorly directed jet. SAM (the most common hemodynamic cause) causes a posterior jet. Flail AML causes a posterior jet. Impingement on the AML restricts the leaflet, causing an anterior jet.\n\nThe answer is (D)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-008", "question": "A 4-week-old male infant is admitted with a 2-day history of poor feeding, lethargy, and vomiting. He was born at term, breastfeeding well until this illness. Vital signs: T 36.8°C, HR 180 bpm, RR 65/min, BP 65/40 mmHg, SpO2 98% room air. He is mottled, with delayed capillary refill. Laboratory studies show: Na 125 mEq/L, K 8.9 mEq/L, Cl 94 mEq/L, CO2 14 mEq/L, glucose 48 mg/dL, Ca 9.8 mg/dL. Point-of-care cortisol is 2 mcg/dL (drawn prior to any steroid administration). Which of the following is the most urgent diagnostic test to confirm the underlying etiology?", "options": ["Plasma renin activity and aldosterone level", "Karyotype analysis", "Serum 17-hydroxyprogesterone level", "ACTH stimulation test", "Urine organic acid analysis"], "answer": "C", "answer_index": 2, "explanation": "The infant presents in acute adrenal crisis with profound hyponatremia, hyperkalemia, hypoglycemia, and low cortisol, diagnostic of primary adrenal insufficiency. The most common cause in a male infant is congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, which is detected by a markedly elevated serum 17-hydroxyprogesterone level. This is the most urgent specific diagnostic test, as it guides definitive management and genetic counseling. Plasma renin activity will be elevated, but does not specify the etiology. Karyotype is not urgent; males with CAH have a 46,XY karyotype. An ACTH stimulation test is diagnostic for adrenal insufficiency but is contraindicated in acute crisis and does not identify the specific enzyme defect. Urine organic acids help diagnose other metabolic disorders.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "This patient is a 4-week-old male infant presenting with signs of an adrenal crisis, specifically the salt-wasting form. The clinical features include shock (hypotension, tachycardia, poor perfusion), hypoglycemia, and the classic electrolyte abnormalities of mineralocorticoid deficiency: hyponatremia and hyperkalemia.\n\nThe most common cause of adrenal insufficiency and salt-wasting in the neonatal period is Congenital Adrenal Hyperplasia (CAH), specifically 21-hydroxylase deficiency. While females with this condition often present at birth with ambiguous genitalia, males typically have normal genitalia and present between 1 and 4 weeks of life with a salt-wasting crisis.\n\nTo confirm the underlying etiology (21-hydroxylase deficiency):\n*   Serum 17-hydroxyprogesterone (17-OHP) is the precursor hormone that accumulates directly upstream of the enzymatic block (21-hydroxylase). markedly elevated levels are diagnostic for classical 21-hydroxylase deficiency.\n\nWhy the other options are less appropriate:\n*   A (Renin/Aldosterone): While renin would be elevated and aldosterone low, this confirms mineralocorticoid deficiency but does not specify the enzyme defect or distinguish it from conditions like adrenal hypoplasia congenital or aldosterone synthase deficiency as definitively as 17-OHP does for CAH.\n*   B (Karyotype): The infant is a phenotypic male. While CAH affects both sexes, karyotype does not diagnose the metabolic/enzymatic defect.\n*   D (ACTH stimulation test): While this is the gold standard for diagnosing adrenal insufficiency, the infant already has a dangerously low cortisol (2 mcg/dL) in the setting of severe stress, which confirms insufficiency. To identify the *specific etiology* (CAH), measuring the specific precursor (17-OHP) is the most direct and urgent test. In a crisis suspecting CAH, 17-OHP is the critical sample to obtain.\n*   E (Urine organic acids): This is for diagnosing inborn errors of metabolism (e.g., organic acidemias). While the child has metabolic acidosis and vomiting, the severe hyperkalemia and hyponatremia point specifically to an adrenal (mineralocorticoid) issue rather than a general metabolic defect.\n\nThe answer is (C)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-009", "question": "A 32-year-old woman with a history of systemic sclerosis (limited cutaneous variant, anti-centromere positive) presents to the rheumatology clinic for routine follow-up. She reports excellent control of her Raynaud's phenomenon and stable skin disease. She has no cardiac or renal symptoms. Her vital signs are normal. A screening transthoracic echocardiogram is performed, which reveals normal left and right ventricular size and function, but there is a small to moderate pericardial effusion. Which of the following findings on echocardiogram would be the strongest indicator to initiate specific pharmacologic therapy directed at the effusion?", "options": ["Right atrial diastolic collapse", "Respiratory variation in mitral inflow velocity >25%", "Inferior vena cava plethora with <50% collapse on sniff", "Swinging heart motion", "Left atrial compression during systole"], "answer": "C", "answer_index": 2, "explanation": "In a patient with a chronic, stable effusion (like those common in connective tissue diseases), the strongest echocardiographic sign of hemodynamic compromise (tamponade physiology) is inferior vena cava (IVC) plethora with minimal respiratory collapse (<50%). This indicates elevated right atrial pressure. In chronic effusions, the chambers have had time to adapt, so classic signs like right atrial collapse may be absent or late. Respiratory variation in mitral inflow (>25%) is a sensitive sign but can be seen in other conditions like COPD. Right atrial collapse is an early sign but less specific in chronic settings. Swinging heart is seen with very large effusions but not specific for tamponade. Left atrial compression is rare.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "This patient with systemic sclerosis (SSc) has a small to moderate pericardial effusion. Pericardial effusions in SSc can be caused by active pericarditis, pulmonary arterial hypertension (PAH) with right heart failure, uremia (scleroderma renal crisis), or can be idiopathic/asymptomatic.\n\nThe patient has normal right ventricular size and function, which makes PAH-induced effusion unlikely (as PAH typically causes RV dilation and dysfunction). She has normal vital signs and no renal symptoms, making scleroderma renal crisis unlikely. Thus, the effusion is likely due to primary pericardial involvement (serositis) or is a chronic asymptomatic effusion.\n\nHowever, the question asks for the strongest indicator to initiate specific pharmacologic therapy. In SSc, asymptomatic pericardial effusions are generally observed. Intervention is reserved for those that are symptomatic or hemodynamically significant. Drainage (pericardiocentesis) is associated with high risks in SSc (recurrence, infection, and hemodynamic collapse, especially in PAH, though PAH is less likely here) and is usually reserved for frank tamponade or purulent pericarditis.\n\nConsequently, for a hemodynamically significant effusion (impending tamponade) in a stable SSc patient, pharmacologic therapy (typically corticosteroids or NSAIDs) is often initiated to reduce the effusion and prevent the need for drainage. The decision to treat an asymptomatic patient is driven by echocardiographic evidence of hemodynamic compromise (\"echocardiographic tamponade\").\n\nAmong the options:\nA. Right atrial diastolic collapse is a highly sensitive and early sign of cardiac tamponade (occurring when pericardial pressure exceeds RA pressure). Its presence indicates that the effusion is hemodynamically significant, justifying the initiation of therapy even in the absence of overt clinical symptoms (hypotension, pulsus paradoxus).\nB. Respiratory variation >25% in mitral inflow is a sign of tamponade physiology (pulsus paradoxus) but RA collapse is typically the earlier and more commonly cited \"trigger\" sign for echocardiographic tamponade diagnosis in this context.\nC. IVC plethora is sensitive but non-specific (seen in RHF, PAH, volume overload).\nD. Swinging heart is seen in massive effusions (electrical alternans).\n\nTherefore, the presence of Right atrial diastolic collapse (Option A) is the strongest indicator of hemodynamic significance that would prompt the initiation of specific therapy (e.g., steroids to resolve the effusion/inflammation) in this clinical scenario to prevent progression to clinical tamponade.\n\nThe answer is (A)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed127", "question_id": "20251205T084024622Z_deepseek-v3.2_seed127-010", "question": "A 16-year-old girl is brought to the ED after collapsing during her high school soccer game. She was pulseless and apneic but received immediate bystander CPR and was defibrillated once with ROSC after 4 minutes. Her initial ECG in the ED shows sinus rhythm with diffuse ST-segment elevation in precordial leads V1-V4 and inferior leads II, III, aVF. Bedside echocardiogram shows severe hypokinesis of the mid to apical left ventricle with hypercontractility of the basal segments. Troponin I is elevated at 15 ng/mL. Which of the following is the most critical next step in management to prevent recurrence?", "options": ["Immediate coronary angiography", "Initiation of an intravenous beta-blocker", "Insertion of a wearable cardioverter-defibrillator", "Initiation of intravenous immunoglobulin (IVIG)", "Administration of intravenous calcium gluconate"], "answer": "B", "answer_index": 1, "explanation": "The clinical presentation and echocardiographic findings are classic for Takotsubo (stress) cardiomyopathy, which can rarely present with ventricular fibrillation arrest. The ECG can mimic STEMI. The most critical step to prevent recurrence of malignant arrhythmias in the acute phase is suppression of catecholamine-driven triggered activity with an intravenous beta-blocker. Immediate coronary angiography is often performed to rule out acute coronary syndrome, but the typical regional wall motion abnormality (apical ballooning) and clinical context make it less likely to be the immediate preventive measure for recurrence. ICD implantation is not indicated in the acute phase of a reversible cardiomyopathy. IVIG is for myocarditis. Calcium is for hyperkalemia or calcium channel blocker overdose.", "generator_model": "deepseek-v3.2", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "This patient is a 16-year-old girl who presented with sudden cardiac arrest during exertion, was resuscitated, and now demonstrates ECG findings of diffuse ST-segment elevation and echocardiographic findings typical of apical ballooning (Takotsubo-like pattern).\n\nThe differential diagnosis for exercise-induced cardiac arrest in a young athlete includes:\n1.  Hypertrophic Cardiomyopathy (HCM): Usually shows left ventricular hypertrophy on echo, not apical ballooning.\n2.  Anomalous Aortic Origin of a Coronary Artery (AAOCA): This is the second leading cause of sudden cardiac death in young athletes. The mechanism involves compression of the anomalous coronary artery (usually the left coronary arising from the right sinus or vice versa) during exertion, leading to profound ischemia. This ischemia can cause ventricular fibrillation and, post-resuscitation, can manifest as myocardial stunning that mimics the wall motion abnormalities of Takotsubo cardiomyopathy (apical ballooning) and ST-segment elevation on ECG.\n3.  Takotsubo Cardiomyopathy: While the echo findings are classic, this is a diagnosis of exclusion. Primary Takotsubo is rare in teenagers but can be triggered by physical stress. Importantly, you cannot differentiate Takotsubo from acute coronary occlusion or anomalous coronary artery compression based solely on the echocardiogram and ECG.\n4.  Myocarditis: Can present with ST changes and wall motion abnormalities, but the exertional arrest history strongly points toward a structural or ischemic anomaly.\n\nManagement:\nThe most critical immediate priority is to identify manageable causes of ischemia, particularly coronary artery anomalies or coronary occlusion (e.g., from thrombus or dissection).\nGuidelines for the management of patients with resuscitated cardiac arrest and ST-segment elevation on ECG recommend immediate coronary angiography (Class I recommendation). This allows for the identification of coronary anomalies (which would require surgical correction to prevent recurrence) or other coronary pathology. While Takotsubo is a possible diagnosis, it can only be confirmed after excluding coronary disease.\n\nTreatments like beta-blockers (B), IVIG (D), or calcium gluconate (E) address specific etiologies (arrhythmia/Takotsubo secondary prevention, Myocarditis, electrolyte disturbance) that have not yet been established. A wearable defibrillator (C) is a secondary prevention measure used after the workup is complete or during the recovery phase, not the immediate critical step.\n\nTherefore, the most critical next step to determine the etiology and guide therapy (specifically to rule out or diagnose a surgically correctable coronary anomaly causing the arrest) is coronary angiography.\n\nThe answer is (A)"}]